Synthetic Genomics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synthetic Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10812
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company provides DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages, among others. It provides solutions in genomics research, bioproduction, applied products, and others. Synthetic Genomics caters to academic and commercial research, development organizations, and others. It also offers production of nutritionals, pharmaceuticals, vaccines and bio-industrial products derived from renewable biological resources, among others. The company operates in partnership with other medical organizations to offer its products. Synthetic Genomics is headquartered in San Diego, California, the US.

Synthetic Genomics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Venture Financing 11
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Partnerships 12
Janssen Vaccines & Prevention Enters into Research and Licensing Option Agreement with Synthetic Genomics 12
Synthetic Genomics Expands R&D Agreement with Lung Biotech 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
Licensing Agreements 15
Synthetic Genomics Enters into Licensing Agreement with Arcturus Therapeutics 15
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 16
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 17
Equity Offering 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 19
Asset Transactions 20
C3J Therapeutics Acquires Bacteriophage Assets from Synthetic Genomics 20
Acquisition 21
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 21
Synthetic Genomics Inc – Key Competitors 22
Synthetic Genomics Inc – Key Employees 23
Synthetic Genomics Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Aug 14, 2018: Synthetic Genomics announces changes to its Board of Directors 25
Jun 25, 2018: Synthetic Genomics Names Reinhard J. Ambros As Board Director 26
Government and Public Interest 27
Oct 26, 2017: Synthetic Genomics Partners with Duke Human Vaccine Institute on DARPA Pandemic Prevention Platform Program 27
Product News 28
Aug 22, 2017: BioXp Genomic Workstation Makes European Debut at VIB Research Institute in Belgium 28
Jun 01, 2017: Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis’ Clinical Trials 29
Jan 09, 2017: Synthetic Genomics Launches Vmax Express, a Next-Generation Protein Expression Platform for the Biotech Industry 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Janssen Vaccines & Prevention Enters into Research and Licensing Option Agreement with Synthetic Genomics 12
Synthetic Genomics Expands R&D Agreement with Lung Biotech 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
Synthetic Genomics Enters into Licensing Agreement with Arcturus Therapeutics 15
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 16
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 17
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 19
C3J Therapeutics Acquires Bacteriophage Assets from Synthetic Genomics 20
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 21
Synthetic Genomics Inc, Key Competitors 22
Synthetic Genomics Inc, Key Employees 23
Synthetic Genomics Inc, Subsidiaries 24

List of Figures
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synthetic Genomics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apache Corp (APA):企業の財務・戦略的SWOT分析
    Apache Corp (APA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Norsk Hydro ASA (NHY)-エネルギー分野:企業M&A・提携分析
    Summary Norsk Hydro ASA (Hydro) is a global supplier of aluminum and an electricity producer. Its operations span the value chain, from bauxite extraction to the production of rolled and extruded aluminum products and building systems. Its portfolio of products include bauxite, alumina, extrusion in …
  • Harbor BioSciences, Inc. (formerly Hollis-Eden Pharmaceuticals):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Harbor BioSciences, Inc. (forme …
  • Photon Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Photon Group Limited Mergers an …
  • IRB Infrastructure Developers Ltd:企業の戦略・SWOT・財務情報
    IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report Summary IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • InSightec Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • EMC Corporation:企業の戦略・SWOT・財務分析
    SummaryEMC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Dicerna Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dicerna Pharmaceuticals, Inc. M …
  • Eitzen Maritime Services ASA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Eitzen Maritime Services ASA Me …
  • Arbella Insurance Group:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Arbella Insurance Group" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly f …
  • Tootsie Roll Industries, Inc.:企業の戦略・SWOT・財務情報
    Tootsie Roll Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tootsie Roll Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Proteon Therapeutics Inc (PRTO):企業財務及び戦略的SWOT分析
    Summary Proteon Therapeutics Inc (Proteon) is a biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases such as hemodialysis and peripheral arterial disease. The company is currently enrolling patients in patency-1 and patency-2, which is a pl …
  • Epicurean and Company, Limited (8213):企業概要、財務及び戦略的SWOT分析
    Summary Epicurean and Company, Limited (EACL) is a holding company. The company operates food and beverage businesses. It operates restaurants and offers catering services. EACL’s restaurants include Ginza Bairin, Shirokuma Curry, Xia Fei and Quick & Fresh. The company offers signature dishes such a …
  • Boingo Wireless, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Boingo Wireless, Inc. Mergers a …
  • PKU HealthCare Co., Ltd. (000788):企業概要、財務及び戦略的SWOT分析
    Summary PKU HealthCare Co., Ltd. (PKU HealthCare) formerly Southwest Synthetic Pharmaceutical Corp., Ltd. is a pharmaceutical company. It develops, manufactures and exports biopharmaceutical, synthetic pharmaceutical and active pharmaceutical ingredients (APIs). The company’s product portfolio inclu …
  • Imperial College London(製薬・医療分野):企業M&A動向
    Summary Imperial College London (Imperial) is an educational institution. It offers undergraduate and postgraduate courses in science and technology, agriculture, business, the humanities, and medicine. The institute operates the departments such as advanced biotechnology centre, aeronautics, airway …
  • Viasystems Group, Inc. (VIAS):企業の財務及び戦略的SWOT分析
    Summary Viasystems Group, Inc., a subsidiary of TTM Technologies, Inc. is an electronic manufacturing company that supplies printed circuit boards (PCBs) and electro-mechanical solutions (E-MS). It is a supplier of complex multi-layer rigid, flexible, and rigid-flex PCBs and E-MS for the automotive, …
  • NWF Group plc (NWF):企業概要、財務及び戦略的SWOT分析
    Summary NWF Group plc (NWF) is a warehousing and distribution company. The company operates through three divisions including food, feeds, and fuels. Its food division conducts warehousing and distribution of client’s grocery and other products to supermarket and other retail distribution centers. N …
  • Madhya Pradesh Power Generating Company Limited:企業概要及び戦略的SWOT分析
    Madhya Pradesh Power Generating Company Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆